microRNA-9 attenuates amyloidβ-induced synaptotoxicity by targeting calcium/calmodulin-dependent protein kinase...

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Alzheimer's disease (AD) involves amyloid-beta (Aβ42) oligomers that induce synaptotoxicity.
• The calcium/calmodulin-dependent protein kinase kinase 2, adenosine monophosphate-activated protein kinase (CAMKK2-AMPK) pathway is implicated in Aβ42-induced neuronal damage.
• MicroRNAs (miRNAs), including synapse-enriched miR-9, are downregulated in AD and may modulate Aβ42 toxicity.

Purpose of the Study:

• To investigate the role of miR-9 in regulating the CAMKK2-AMPK pathway activation.
• To determine if miR-9 can mitigate Aβ42-induced synaptotoxicity and neuronal dysfunction.
• To identify CAMKK2 as a direct target of miR-9.

Main Methods:

• Overexpression of miR-9 in neuronal models exposed to Aβ42 oligomers.
• Bioinformatic prediction of miR-9 targets (Pictar, Targetscan 6.2).
• Luciferase activity assays and Western blot analysis to validate miR-9 targeting of CAMKK2.
• Assessment of dendritic spine density and tau phosphorylation (Ser-262) following miR-9 intervention.

Main Results:

• Aβ42 oligomers activated the CAMKK2-AMPK pathway, which was suppressed by miR-9 overexpression.
• Bioinformatics and experimental validation confirmed CAMKK2 as a direct target of miR-9.
• miR-9 overexpression restored dendritic spine morphology and reduced Aβ42-induced tau phosphorylation at Ser-262.
• miR-9 attenuated Aβ42-induced synaptotoxicity by inhibiting CAMKK2.

Conclusions:

• miR-9 plays a protective role against Aβ42-induced synaptotoxicity.
• Targeting CAMKK2 via miR-9 modulation represents a potential therapeutic strategy for Alzheimer's disease.
• The miR-9/CAMKK2 axis is a critical regulator of neuronal response to amyloid-beta pathology.